Greg Little

About Greg Little

25+ years of progressive global leadership and board experience developing and executing strategy, building and leading commercial, operational, finance, and people functions. Success across divisions, segments, businesses, regions, and enterprise-wide resulting in increased market share and strong results growing revenue and profit margins. Proven global operator with: full P&L ownership from launch to $600M; success scaling (2 startup exits:$4.3B IPO and $350M strategic acquisition); worldwide launches in software and medtech (15+ Class incl. 3 FDA Breakthrough); leading product dev & innovation strategy (11 patents/pending); and executing M&A transactions/integrations ($12B,$350M,$94M,$80M deals). Success building and leading on-site and virtual teams while physically located across multiple U.S. states, Latin America, and China. Experienced influencing critical executive decision-making in startups, regional enterprises, and Fortune 500 global matrix orgs. Board leadership experience (3 startup and 3 non-profit) and startup advisory (venture capital LP and angel investor). Led commercialization for the first two software FDA Breakthrough devices approved.Developed, launched, and grew- AI: machine learning, deep learning, and augmented reality solutions- IoT solutions- Regulated and non-regulated software, incl. software as medical device (SAMD)- Digital health and medical device solutions (therapeutics, diagnostics, imaging and sequencing CDx, implantables, consumables) in immuno-oncology, genomics (NGS), women’s health, pulmonology, hematology, infectious disease, autoimmune, and other disease states. MBA Global Strategy, Marketing from Darden GSB (University of Virginia). MBA studies at Peking University, Guanghua School of Management ().B.S. Biology from Brigham Young University. Other university studies in: computer engineering, law, China business, genetics, human physiology. 11 patents and pending.English (Native); Spanish (Fluent); Mandarin (Basic); French (Learning)

Experience

1. CEO & Founder

   Grodivo.Ai

   Jan 2024 — Present · US

   Aligning the #futureofwork with an amazing AI-powered SaaS platform built by an experienced team (5 exits @$7B+ in EV) that quantifies company culture, based on the latest people science.

Skills

• Financial Modeling
• Market Research
• Financial Analysis
• Medical Diagnostics
• Ngs
• Business Strategy
• Competitive Analysis
• Start-Ups
• Strategic Planning
• Cross-Functional Team Leadership
• Latin America
• Marketing Strategy
• Consulting
• Executive Management
• Product Marketing
• Mergers & Acquisitions
• Corporate Branding
• Strategy
• Oncology
• International Strategy
• Medical Devices
• Product Development
• Management
• Immunosequencing
• Marketing Communications
• Management Consulting
• Leadership
• Product Launch
• Marketing
• P&L Management
• Business Development
• Negotiation
• Market Analysis
• China
• Product Management